This promising anti-aging drugs just failed its human test
One of the most studied lifespan-extending drugs in animals has just failed its test on humans in a 13-week clinical trial co-funded by DeSci community VitaDAO. The trial led by Dr. Brad Stanfield, a General Practitioner based in Auckland, New Zealand, sought to know how the so-called drug “rapamycin,” combined with exercise, fares in older […]
- Read at Cryptopolitan
- Fri, 17 Apr 2026 01:27:00 +0000